Ribavirin/sofosbuvirLack of efficacy: 5 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2020年 / 1833卷 / 1期

关键词：

D O I：

10.1007/s40278-020-87155-6

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：337 / 337

相关论文

共 50 条

[21] RamucirumabLack of efficacy: 5 case reports
Reactions Weekly, 2021, 1880 (1) : 333 - 333
[22] DapagliflozinLack of efficacy: 5 case reports
Reactions Weekly, 2025, 2040 (1) : 289 - 289
[23] InfliximabLack of efficacy: 5 case reports
Reactions Weekly, 2023, 1954 (1) : 252 - 252
[24] AntineoplasticsLack of efficacy: 5 case reports
Reactions Weekly, 2022, 1931 (1) : 71 - 71
[25] MultipleLack of efficacy: 5 case reports
Reactions Weekly, 2022, 1915 (1) : 279 - 279
[26] CefazolinLack of efficacy: 5 case reports
Reactions Weekly, 2024, 2035 (1) : 138 - 138
[27] HydroxycarbamideLack of efficacy: 5 case reports
Reactions Weekly, 2021, 1853 (1) : 228 - 228
[28] ImmunosuppressantsLack of efficacy: 5 case reports
Reactions Weekly, 2023, 1944 (1) : 309 - 309
[29] CatequentinibLack of efficacy: 5 case reports
Reactions Weekly, 2023, 1939 (1) : 131 - 131
[30] VismodegibLack of efficacy: 5 case reports
Reactions Weekly, 2023, 1946 (1) : 538 - 538

← 1 2 3 4 5 →